Pawlak-Buś Katarzyna

7PUBLICATIONS
11CO-AUTHORS
AutoimmunityOptical technologyMolecular medicinePredictive and prognostic markersRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 09, 2025
Chronic intestinal pseudo-obstruction in the course of systemic sclerosis successfully treated with intravenous immunoglobulins and rituximab.

Julia Kołodziejczyk, Izabella Ławińska, Wiktor Schmidt

|Jun 09, 2025
Clinical expert statement on osteoarthritis: diagnosis and therapeutic choices.

Piotr Leszczyński, Przemysław Lisiński, Brygida Kwiatkowska

|May 12, 2023
Current treatment of systemic lupus erythematosus: a clinician's perspective.

Pawlak-Buś Katarzyna, Schmidt Wiktor, Dudziec Ewa

|Mar 29, 2023
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience.

Wiktor Schmidt, Katarzyna Pawlak-Buś, Barbara Jóźwiak

|Jul 05, 2022
2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists.

Katarzyna Pawlak-Buś, Piotr Leszczyński

|Jul 05, 2022
Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients - the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response - results from the multicenter observational ACT-POL study.

Marcin Stajszczyk, Sławomir Jeka, Anna Juś

Pageof 2

Frequent Collaborators

4 joint publications

Wiktor Schmidt

4 joint publications

Piotr Leszczyński

1 joint publications

Sławomir Jeka

1 joint publications

Barbara Jóźwiak